Accurate Molecular Classification of Kidney Cancer Subtypes Using MicroRNA Signature

2011 ◽  
Vol 59 (5) ◽  
pp. 721-730 ◽  
Author(s):  
Youssef M. Youssef ◽  
Nicole M.A. White ◽  
Jörg Grigull ◽  
Adriana Krizova ◽  
Christina Samy ◽  
...  
2018 ◽  
Vol 8 (12) ◽  
pp. 2422 ◽  
Author(s):  
Ali Muhamed Ali ◽  
Hanqi Zhuang ◽  
Ali Ibrahim ◽  
Oneeb Rehman ◽  
Michelle Huang ◽  
...  

Kidney cancer is one of the deadliest diseases and its diagnosis and subtype classification are crucial for patients’ survival. Thus, developing automated tools that can accurately determine kidney cancer subtypes is an urgent challenge. It has been confirmed by researchers in the biomedical field that miRNA dysregulation can cause cancer. In this paper, we propose a machine learning approach for the classification of kidney cancer subtypes using miRNA genome data. Through empirical studies we found 35 miRNAs that possess distinct key features that aid in kidney cancer subtype diagnosis. In the proposed method, Neighbourhood Component Analysis (NCA) is employed to extract discriminative features from miRNAs and Long Short Term Memory (LSTM), a type of Recurrent Neural Network, is adopted to classify a given miRNA sample into kidney cancer subtypes. In the literature, only a couple of kidney subtypes have been considered for classification. In the experimental study, we used the miRNA quantitative read counts data, which was provided by The Cancer Genome Atlas data repository (TCGA). The NCA procedure selected 35 of the most discriminative miRNAs. With this subset of miRNAs, the LSTM algorithm was able to group kidney cancer miRNAs into five subtypes with average accuracy around 95% and Matthews Correlation Coefficient value around 0.92 under 10 runs of randomly grouped 5-fold cross-validation, which were very close to the average performance of using all miRNAs for classification.


2018 ◽  
Vol 14 (4) ◽  
pp. 217-224 ◽  
Author(s):  
Aravind Sanjeevaiah ◽  
Naga Cheedella ◽  
Caitlin Hester ◽  
Matthew R. Porembka

Gastric adenocarcinoma remains an aggressive and poorly understood malignancy with a heterogeneous presentation and tumor biology. The current histologic and anatomic classification has been ineffective in guiding therapy, with only marginal improvement in outcome over time. Furthermore, the variation in presentation and disease among racial and ethnic groups amplifies the complexity of this cancer. An understanding of the clinical and molecular variability is important for effective treatment. Recent advances in molecular biology have better defined gastric cancer subtypes. We systematically review recent literature on the molecular classification of gastric adenocarcinoma and the associated management implications, with an emphasis on Hispanic and Native American populations.


2015 ◽  
Vol 26 ◽  
pp. iii15
Author(s):  
H.H. Milioli ◽  
I. Tishchenko ◽  
C. Riveros ◽  
R. Berretta ◽  
P. Moscato

Author(s):  
Antonio Pico ◽  
Laura Sanchez-Tejada ◽  
Ruth Sanchez-Ortiga ◽  
Rosa Camara ◽  
Cristina Lamas ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document